You searched for metabolic diseases - Page 51 of 62

Unlocking AAV gene therapy potential: The role of successful characterization

…are not yet fully understood. AAVs have considerable potential for developing new therapies for untreatable genetic diseases, including ocular, neuromuscular, neurodegenerative, cardiovascular, and metabolic disorders and cancer. Several AAV serotypes…

November 5, 2024 - 8 minutesmins - By Ute Boronowsky

News and Trends 27 Sep 2018

Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward

…the small and large intestines, where it interacts with its host’s metabolism and immune system. According to Cani, the bacterium has been shown to improve metabolic and inflammatory disorders in…

September 27, 2018 - 2 minutesmins - By Alexander Burik

omics aromics barcelona panorama mesothelioma

Startup Scout 12 Jul 2019

This Biotech Uses ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

…omics techniques, such as metabolomics, which measures how drugs affect levels of metabolic molecules. Founded in 2005 in Barcelona, Spain, Aromics is also developing its lead compound to treat lung…

July 12, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 18 May 2023

Could a salt flats pigment treat cancer?

…its effect on enzymes (biocatalysts) involved in pathologies such as diabetes and metabolic syndrome. After these results were made public, they wondered what would happen if they added the salt…

May 18, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 24 Nov 2016

A Finnish Company opens a New Avenue to Alternative Protein

…carbon footprint and can be produced from different types of waste and residues. It has caught the interest of biotechs like Global Bioenergies, which engineered a new metabolic pathway for…

November 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 20 Feb 2024

Biotechs in the US Capital: seven key players based in Washington DC

…designed to identify clinical candidates for diseases characterized by underlying mitochondrial dysfunction. One of the company’s focuses is medication-resistant epilepsy. A research team led by the co-founder of the company…

February 20, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 15 Mar 2023

7 biotechs in Hungary you should know about

…for cancer, drug resistance and metabolic disorders. The company now sells more than 100 products targeted at pharma and drug discovery companies. A big name in Hungary and across Europe,…

March 15, 2023 - 9 minutesmins - By Alex Dale

News and Trends 4 May 2023

World’s first RSV vaccine for older adults gets FDA approval

…significant burden of RSV. Arexvy is the first approved RSV vaccine for older adults, expanding GSK’s industry-leading vaccine portfolio, which protects millions of people from infectious diseases each year. Our…

May 4, 2023 - 5 minutesmins - By Jim Cornall

fecal transplant diabetes netherlands2 1

News and Trends 5 Oct 2017

Dutch Clinical Trial Points to Fecal Transplant as Diabetes Treatment

…Current treatments include supplementary insulin and blood pressure control. The study recruited 38 obese men with metabolic syndrome, a condition where patients suffer from high blood pressure, high blood sugar…

October 5, 2017 - 3 minutesmins - By Alex Dale

News and Trends 11 Jan 2023

What’s in store for biotech in 2023?

…have new models of human cells available to study and treat diseases. Neurodegenerative disease and metabolic disease research and drug discovery will likely be some of the first areas that…

January 11, 2023 - 14 minutesmins - By Jim Cornall

Erytech pharma Queens university red blood cells

News and Trends 12 Jul 2017

French Biotech and Canadian University to treat Rare Disease with Red Blood Cells

…to treat arginase-1 deficiency, a rare metabolic disorder that causes the excessive accumulation of asparagine in the blood and brain. In collaboration with experts from Queen’s University in Canada, Erytech…

July 12, 2017 - 1 minutemin - By Clara Rodríguez Fernández

More News! 4 Nov 2022

Alimentiv and Summit collaborate to tackle liver disease NASH

…unmet clinical need and attractive commercial opportunity, Alimentiv and Summit say there are currently no FDA-approved therapies for this disease. Several therapeutic agents targeting different metabolic pathways are currently in…

November 4, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Unlocking AAV gene therapy potential: The role of successful characterization

Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward

This Biotech Uses ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

Could a salt flats pigment treat cancer?

A Finnish Company opens a New Avenue to Alternative Protein

Biotechs in the US Capital: seven key players based in Washington DC

7 biotechs in Hungary you should know about

World’s first RSV vaccine for older adults gets FDA approval

Dutch Clinical Trial Points to Fecal Transplant as Diabetes Treatment

What’s in store for biotech in 2023?

French Biotech and Canadian University to treat Rare Disease with Red Blood Cells

Alimentiv and Summit collaborate to tackle liver disease NASH

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!